About N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine
N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine (PubChem CID 46983876) has the molecular formula C18H20ClN5
and a molecular weight of 341.85 g/mol. Its IUPAC name is N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine.
Analyze N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine?
The IUPAC name of N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine (CID 46983876) is N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine.
What is the SMILES notation for N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine?
The canonical SMILES for N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine is Cc1nn(C)c(C)c1-c1ccnc(NC(C)c2ccc(Cl)cc2)n1.
What is the InChIKey of N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine?
The InChIKey is NNECGRABUIPGPH-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H20ClN5/c1-11(14-5-7-15(19)8-6-14)21-18-20-10-9-16(22-18)17-12(2)23-24(4)13(17)3/h5-11H,1-4H3,(H,20,21,22).
What are the key properties of N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine?
N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine has a molecular weight of 341.85 g/mol, XLogP of 4.32, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(4-chlorophenyl)ethyl]-4-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-2-amine is sourced from PubChem (CID 46983876), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).